# Role of BMP Pathway in MDS Progression

> **NCT06175923** · — · NOT_YET_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 60 (estimated)

## Conditions studied

- Myelodysplastic Syndromes
- Acute Myelogenous Leukemia

## Interventions

- **BIOLOGICAL:** Collection of EDTA (disodium salt of ethylenediaminetetraacetic acid) tubes of marrow during routine care

## Key facts

- **NCT ID:** NCT06175923
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-27
- **Primary completion:** 2029-01-27
- **Final completion:** 2034-01-27
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06175923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06175923, "Role of BMP Pathway in MDS Progression". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06175923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*